Tirzepatide, a recently approved medication, is creating significant excitement in the scientific community as a viable treatment for both diabetes, type 2 and weight loss . This groundbreaking drug works by targeting two separate receptors, GLP-1 and GIP, leading to better glucose control and significant weight reduction in research studies . Whil